These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 10956013)

  • 1. Efficient, Mg(2+)-dependent photochemical DNA cleavage by the antitumor quinobenzoxazine (S)-A-62176.
    Yu H; Kwok Y; Hurley LH; Kerwin SM
    Biochemistry; 2000 Aug; 39(33):10236-46. PubMed ID: 10956013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Self-assembly of a quinobenzoxazine-Mg2+ complex on DNA: a new paradigm for the structure of a drug-DNA complex and implications for the structure of the quinolone bacterial gyrase-DNA complex.
    Fan JY; Sun D; Yu H; Kerwin SM; Hurley LH
    J Med Chem; 1995 Feb; 38(3):408-24. PubMed ID: 7853333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural insight into a quinolone-topoisomerase II-DNA complex. Further evidence for a 2:2 quinobenzoxazine-mg2+ self-assembly model formed in the presence of topoisomerase ii.
    Kwok Y; Zeng Q; Hurley LH
    J Biol Chem; 1999 Jun; 274(24):17226-35. PubMed ID: 10358081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The quinobenzoxazines: relationship between DNA binding and biological activity.
    Kwok Y; Sun D; Clement JJ; Hurley LH
    Anticancer Drug Des; 1999 Oct; 14(5):443-50. PubMed ID: 10766299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quinolones share a common interaction domain on topoisomerase II with other DNA cleavage-enhancing antineoplastic drugs.
    Elsea SH; Westergaard M; Burden DA; Lomenick JP; Osheroff N
    Biochemistry; 1997 Mar; 36(10):2919-24. PubMed ID: 9062121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Photocleavage of DNA by the fluoroquinolone antibacterials.
    Martínez L; Chignell CF
    J Photochem Photobiol B; 1998 Aug; 45(1):51-9. PubMed ID: 9819899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of eukaryotic topoisomerase II cleavage sites in the presence of the quinolone CP-115,953 reveals drug-dependent and -independent recognition elements.
    Spitzner JR; Chung IK; Gootz TD; McGuirk PR; Muller MT
    Mol Pharmacol; 1995 Aug; 48(2):238-49. PubMed ID: 7651357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Action of quinolones against Staphylococcus aureus topoisomerase IV: basis for DNA cleavage enhancement.
    Anderson VE; Zaniewski RP; Kaczmarek FS; Gootz TD; Osheroff N
    Biochemistry; 2000 Mar; 39(10):2726-32. PubMed ID: 10704224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Light-activated cleavage of DNA by cobalt-bleomycin.
    Nightingale KP; Fox KR
    Eur J Biochem; 1994 Feb; 220(1):173-81. PubMed ID: 7509745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis, and evaluation of psorospermin/quinobenzoxazine hybrids as structurally novel antitumor agents.
    Kim MY; Na Y; Vankayalapati H; Gleason-Guzman M; Hurley LH
    J Med Chem; 2003 Jul; 46(14):2958-72. PubMed ID: 12825936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sequence-selective binding of an ellipticine derivative to DNA.
    Bailly C; OhUigin C; Rivalle C; Bisagni E; Hénichart JP; Waring MJ
    Nucleic Acids Res; 1990 Nov; 18(21):6283-91. PubMed ID: 2173825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specific interaction of camptothecin, a topoisomerase I inhibitor, with guanine residues of DNA detected by photoactivation at 365 nm.
    Leteurtre F; Fesen M; Kohlhagen G; Kohn KW; Pommier Y
    Biochemistry; 1993 Aug; 32(34):8955-62. PubMed ID: 8395887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bleomycin-dependent damage to the bases in DNA is a minor side reaction.
    Gajewski E; Aruoma OI; Dizdaroglu M; Halliwell B
    Biochemistry; 1991 Mar; 30(9):2444-8. PubMed ID: 1705818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of topoisomerase II-targeted drugs on enzyme-mediated DNA cleavage and ATP hydrolysis: evidence for distinct drug interaction domains on topoisomerase II.
    Robinson MJ; Corbett AH; Osheroff N
    Biochemistry; 1993 Apr; 32(14):3638-43. PubMed ID: 8385484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design of new topoisomerase II inhibitors based upon a quinobenzoxazine self-assembly model.
    Zeng Q; Kwok Y; Kerwin SM; Mangold G; Hurley LH
    J Med Chem; 1998 Oct; 41(22):4273-8. PubMed ID: 9784102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibacterial studies, DNA oxidative cleavage, and crystal structures of Cu(II) and Co(II) complexes with two quinolone family members, ciprofloxacin and enoxacin.
    Jiménez-Garrido N; Perelló L; Ortiz R; Alzuet G; González-Alvarez M; Cantón E; Liu-González M; García-Granda S; Pérez-Priede M
    J Inorg Biochem; 2005 Mar; 99(3):677-89. PubMed ID: 15708788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo topoisomerase II cleavage sites in the ribosomal DNA of Physarum polycephalum.
    Borde V; Duguet M
    Biochemistry; 1996 May; 35(18):5787-95. PubMed ID: 8639539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition by singlet oxygen quenchers of oxidative damage to DNA produced in cultured cells by exposure to a quinolone antibiotic and ultraviolet A irradiation.
    Verna LK; Chen D; Schluter G; Williams GM
    Cell Biol Toxicol; 1998 Jun; 14(3):237-42. PubMed ID: 9689496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Participation of reactive oxygen species in phototoxicity induced by quinolone antibacterial agents.
    Umezawa N; Arakane K; Ryu A; Mashiko S; Hirobe M; Nagano T
    Arch Biochem Biophys; 1997 Jun; 342(2):275-81. PubMed ID: 9186488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antitumor quinolones with mammalian topoisomerase II mediated DNA cleavage activity.
    Yamashita Y; Ashizawa T; Morimoto M; Hosomi J; Nakano H
    Cancer Res; 1992 May; 52(10):2818-22. PubMed ID: 1316228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.